DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-4,028 Cr | ₹-4,137 Cr | ₹-2,639 Cr | ₹-2,266 Cr | ₹-492 Cr |
What is the latest Cash Flow from Investing Activities ratio of DR REDDYS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-4,028 Cr |
Mar2023 | ₹-4,137 Cr |
Mar2022 | ₹-2,639 Cr |
Mar2021 | ₹-2,266 Cr |
Mar2020 | ₹-492 Cr |
How is Cash Flow from Investing Activities of DR REDDYS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4,028 Cr | Negative | |
Mar2023 | ₹-4,137 Cr | Negative | |
Mar2022 | ₹-2,639 Cr | Negative | |
Mar2021 | ₹-2,266 Cr | Negative | |
Mar2020 | ₹-492 Cr | - |
Compare Cash Flow from Investing Activities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹99,673.3 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -4.1% |
-10.8% |
9.5% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses